CHUGAI PHARMACEUTICAL CO., LTD.

Print

Translation

Nov 14, 2017

Concerning Today's Certain Media Report

Tokyo, November 14, 2017 -- There was a media report by Nikkei today that Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) has decided to divest its off-patent drug business to a third party. However, this report is not based on any announcement made by Chugai or information provided by Chugai.

It is our policy to fairly and timely disclose material information including information which may impact the share price. Chugai has and will maintain this policy.

Contact:
For Media
Chugai Pharmaceutical Co., Ltd.
Media Relations Group, Corporate Communications Dept.,
Koki Harada
Tel: +81-3-3273-0881
E-mail: pr@chugai-pharm.co.jp

For Investors
Chugai Pharmaceutical Co., Ltd.
Investor Relations Group, Corporate Communications Dept.,
Toshiya Sasai
Tel: +81-3-3273-0554
E-mail: ir@chugai-pharm.co.jp

 

 

[ PDF 45KB]

To view PDF files,
you will need Adobe® Reader® which is available as a free download.

Close